Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes: the SURPASS-6 randomized clinical trial

J Rosenstock, JP Frías, HW Rodbard, S Tofé, E Sears… - Jama, 2023 - jamanetwork.com
Importance Tirzepatide is a glucose-dependent insulinotropic polypeptide and glucagon-like
peptide-1 receptor agonist used for the treatment of type 2 diabetes. Efficacy and safety of …
被引用次数：30 相关文章

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.

J Rosenstock, JP Frías, HW Rodbard, S Tofé, E Sears… - JAMA, 2023 - europepmc.org
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6
Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[PDF] japic.or.jp

[PDF][PDF] JAPIC Pharma Report

J Rosenstock - JAMA The Journal of the American Medical Association, 2023 - japic.or.jp
JAPIC Pharma Report Page 1 JAPIC Pharma Report 海外医薬情報(文献情報) 1 JAPIC Pharma
Report 海外医薬情報 2024 年 2 月号 (文献情報) ★202350879 2 型糖尿病における基礎 Insulin に …
[HTML] nih.gov

[HTML][HTML] Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial

J Rosenstock, JP Frías, HW Rodbard, S Tofé, E Sears… - JAMA, 2023 - ncbi.nlm.nih.gov
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial

J Rosenstock, JP Frías, HW Rodbard, S Tofé… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Importance Tirzepatide is a glucose-dependent insulinotropic polypeptide and glucagon-like
peptide-1 receptor agonist used for the treatment of type 2 diabetes. Efficacy and safety of …

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.

J Rosenstock, JP Frías, HW Rodbard… - JAMA: Journal of …, 2023 - search.ebscohost.com
Abstract Key Points: Question: What is the effect on glycemic control of adding once-weekly
tirzepatide vs thrice-daily prandial insulin lispro to insulin glargine treatment in inadequately …

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.

J Rosenstock, JP Frías, HW Rodbard, S Tofé, E Sears… - JAMA, 2023 - europepmc.org
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6
Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[引用][C] Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes The SURPASS-6 Randomized Clinical Trial

J Rosenstock, JP Frías, HW Rodbard, S Tofé, E Sears - JAMA, 2023

[引用][C] Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes The SURPASS-6 Randomized Clinical Trial

J Rosenstock, JP Frías, HW Rodbard, S Tofé, E Sears - JAMA, 2023